In a report released today, Alex Fuhrman from Craig-Hallum assigned a Buy rating to LifeVantage (LFVN – Research Report). The company’s shares ...

LifeVantage (NASDAQ:LFVN – Get Free Report) is projected to announce its earnings results before the market opens on Tuesday, January 28th. Analysts expect the company to announce earnings of $0.14 ...

Fintel reports that on January 14, 2025, Craig-Hallum initiated coverage of LifeVantage (NasdaqCM:LFVN) with a Buy recommendation. Analyst Price Forecast Suggests 3.07% Upside As of December 23, 2024, ...

LifeVantage (NASDAQ:LFVN – Get Free Report) and Checkpoint Therapeutics (NASDAQ:CKPT – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the ...

Their product line includes the Protandim® family ... assigning a Buy rating and setting a price target of $35.00. The firm highlighted the company’s recent success with its MindBody GLP ...

Their product line includes the Protandim® family, TrueScience® Liquid Collagen ... Analysts at Craig-Hallum initiated coverage on LifeVantage, assigning a Buy rating and setting a price target of $35 ...

It offers Protandim, a dietary supplement ... LifeVantage Corporation’s Stock Price as of Market Close As of January 14, 2025, 4:00 PM, CST, LifeVantage Corporation’s stock price was $25.62.

Commissions do not affect our editors' opinions or evaluations. The price of gold today, as of 9:12 am ET, was $2,760.15 per ounce. That’s down 0.17% from yesterday’s gold price of $2,764.87.